PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma

European Journal of Nuclear Medicine & Molecular Imaging, 05/10/2012

PET with 68Ga–labelled somatostatin analogues allows the pretherapeutic assessment of tumour radionuclide uptake in peptide receptor radionuclide therapy (PRRT) of meningioma and an estimate of the achievable dose.

Print Article Summary Cat 2 CME Report